Viewing StudyNCT04851834

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 4:02 PM
Last Modification Date: 2024-10-26 @ 2:02 PM
Study NCT ID: NCT04851834
Status: TERMINATED
Last Update Posted: 2022-12-20
First Post: 2021-04-08
Brief Title: NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Sponsor: Xennials Therapeutics Australia Pty Ltd
Organization: Xennials Therapeutics Australia Pty Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumor
Platinum-Resistant Ovarian Cancer
Platinum-Resistant Urothelial Carcinoma
High-grade Glioma
Keywords:
Name View
Hypomethylating Agent View
Nucleoside Analog View
DNA Demethylation View
Solid Tumors View
Ovarian Neoplasms View
Urinary Bladder Neoplasms View
Platinum-resistant View
Carboplatin View
Cisplatin View
Glioma View
IDH1 View
Temozolomide View